Law & Regulation
US musician, ex-paratrooper Michael Travis Leake arrested in Moscow on drug trafficking charges
An American musician who has lived in Russia for more than a decade has been arrested on suspicion of drug trafficking, Russian news media reported Saturday….
An American musician who has lived in Russia for more than a decade has been arrested on suspicion of drug trafficking, Russian news media reported Saturday.
The reports said Michael Travis Leake is suspected of selling mephedrone, whose effects are similar to those of cocaine and MDMA.
A Moscow court ordered him to be held for two months in pre-trial detention, the reports said.
He faces charges of production or distribution of drugs, which carry a sentence of up to 20 years in prison.
An Instagram page under the name Travis Leake Instagram identifies him as the singer for the band Lovi Noch (Seize the Night).
News reports said Leake is a former paratrooper with the US military and has lived in Moscow since 2010.
Russian drug laws are strict.
WNBA star Brittney Griner was arrested in February 2022 after vape canisters containing cannabis oil were found in her luggage at a Moscow airport.
She was sentenced to nine years in prison, but was released in December in an exchange for US-imprisoned Russian arms dealer Viktor Bout.
The US State Department said in an emailed statement to The Associated Press that it was aware of the reports that a US citizen had recently been arrested in Moscow.
It said when a US citizen is detained overseas, the department “pursues consular access as soon as possible and works to provide all appropriate consular assistance.”
The department said it would have no further comment due to privacy considerations.
The post US musician, ex-paratrooper Michael Travis Leake arrested in Moscow on drug trafficking charges appeared first on REPORT DOOR.
laws mdma
-
Psychedelics1 week agoAlgernon NeuroScience and the Centre for Human Drug Research to Present DMT Phase 1 Stroke Clinical Data at the Interdisciplinary Conference on Psychedelic Research June 6 – 8th, 2024
-
Psychedelics1 week agoRevive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
-
Law & Regulation1 week agoTryp Therapeutics merger with Exopharm approved by shareholders
-
Psilocybin1 week agoPassover Perspectives: Psychedelics, Moses, and the Burning Bush
-
Psychedelics1 week agoatai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
-
Psychedelics1 week agoSilo Pharma Announces Positive Results for Intranasal PTSD Treatment
-
Psilocybin1 week agoPsilocybin and Meditation: Unlocking the Potential for Enhancing Insightfulness
-
Psychedelics1 week ago
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID